Last reviewed · How we verify
NCT03436836
Nalbuphine as an Adjuvant to Local Anaesthetic Mixture in Peribulbar Cataract Surgery
NA trial testing Nalbuphine in Nalbuphine as an Adjuvant to L. A in Peribulbar Block for Cataract Surgery in 40 participants. Completed in 28 February 2018.
20 February 2018
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 40 |
| Start date | 14 January 2018 |
| Primary completion | 20 February 2018 |
| Estimated completion | 28 February 2018 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- Nalbuphine — full drug profile →
- lidocaine, bupivacaine, hyaluronidase , saline — full drug profile →
- lidocaine, bupivacaine , hyaluronidase
Conditions studied
- Nalbuphine as an Adjuvant to L. A in Peribulbar Block for Cataract Surgery — all drugs for Nalbuphine as an Adjuvant to L. A in Peribulbar Block for Cataract Surgery →
Sponsor
Cairo University
Who can join
Adults 40 to 60, any sex, with Nalbuphine as an Adjuvant to L. A in Peribulbar Block for Cataract Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Nalbuphine has been used as an adjuvant to bupivacaine in intrathecal, epidural, caudal anesthesia and peripheral nerve blocks showing an increase in the efficacy and the duration of postoperative analgesia.The aim of this study is evaluation of the effect of nalbuphine when used as an adjuvant to a local anesthetic mixture in peribulbar block undergoing cataract surgery
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03436836
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nalbuphine
Trials testing the same drug.
- NCT07197684 — Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surg · NA · not yet recruiting
- NCT07422558 — Intravenous Nalbuphine Versus Lidocaine for Prevention of Propofol Injection Pain · NA · not yet recruiting
- NCT07435337 — Effect of Nalbuphine Versus Fentanyl on Hemdoynamic Effects of Laryngoscopy · Phase 4 · recruiting
- NCT07269106 — Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery · Phase 4 · recruiting
- NCT07279727 — Ultrasound-Guided Infraclvicular Block Using Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Upper Limb · Phase 1 · not yet recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03436836 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 30 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03436836.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing